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Audit of practice in sudden unexpected death in epilepsy (SUDEP) post mortems and
neuropathological findings
Aims: Sudden unexpected death in epilepsy (SUDEP) is
one of the leading causes of death in people with epilepsy.
For classification of definite SUDEP, a post mortem (PM),
including anatomical and toxicological examination, is
mandatory to exclude other causes of death. We audited
PM practice as well as the value of brain examination in
SUDEP.Methods:We reviewed 145 PM reports in SUDEP
cases from four UK neuropathology centres. Data were
extracted for clinical epilepsy details, circumstances of
death and neuropathological findings. Results: Macro-
scopic brain abnormalities were identified in 52% of cases.
Mild brain swelling was present in 28%, and microscopic
pathologies relevant to cause or effect of seizures were
seen in 89%. Examination based on whole fixed brains
(76.6% of all PMs), and systematic regional sampling was
associated with higher detection rates of underlying
pathology (P < 0.01). Information was more frequently
recorded regarding circumstances of death and body
position/location than clinical epilepsy history and
investigations. Conclusion: Our findings support the con-
tribution of examination of the whole fixed brain in
SUDEP, with high rates of detection of relevant pathology.
Availability of full clinical epilepsy-related information at
the time of PM could potentially further improve detection
through targeted tissue sampling. Apart from confirma-
tion of SUDEP, complete neuropathological examination
contributes to evaluation of risk factors as well as helping
to direct future research into underlying causes.
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Introduction
In 2002, the findings from a national UK audit high-
lighted sudden and unexpected deaths in epilepsy as
‘deaths in the shadows’, being systemically under-
recognized, under-reported and poorly investigated by
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health professionals [1]. Sudden unexpected death in epi-
lepsy (SUDEP) is now recognized as a leading cause of
premature death in young adults with epilepsy with an
estimated incidence of 1.16 cases per 1000 people with
epilepsy per year [2] and is currently the focus of interna-
tional initiatives aiming to address causes and identify pre-
ventative strategies [3]. In the UK, an estimated 500
annual epilepsy-related deaths are considered to be SUDEP
(Joint Epilepsy Council UK, 2011). Many of these deaths
are potentially preventable, thus promoting focused, mul-
tidisciplinary research initiatives to understand risk
factors and mechanisms that underpin SUDEP [4]. Post
mortem (PM) examination is requisite for the confirma-
tion of SUDEP, through exclusion of other causes of death.
Correct classification of the cause of death in people with
epilepsy is evidently essential to any future research, and
to epidemiological studies. Examination of the brain also
offers a resource for further investigation and understand-
ing of the different pathological mechanisms that lead to
SUDEP.
The main alternative categories of epilepsy-related
death that are considered at a suspected SUDEP autopsy
are an accident during a seizure (including traumatic
brain injury or drowning), death as a result of a prolonged
seizure (status epilepticus) or aspiration during a seizure
[5]. In themajority of such deaths in England, a Coroner’s
PM is mandated (outer membrane procedures in many
other countries). The main objectives are to exclude other
diseases which can both mimic seizures in life and be a
cause of sudden death (e.g. cardiac disease), to identify a
cause for epilepsy, and to provide accurate PM data on the
mode of death for any inquiry and for deaths registers.
Acceptance of SUDEP was an important issue prior to
the National Sentinel Audit in 2002 [1]. A UK national
confidential enquiry (NCEPOD) in 2006 into Coroners’
autopsies also highlighted examinations in epilepsy
deaths, including brain examination, as an area of specific
concern. Guidelines for autopsy practice in epilepsy deaths
were devised in 2006 by the UK Royal College of Patholo-
gists (www.rcpath.org). The key recommendations were
that (i) the pathologist should have information regarding
epilepsy, including seizure control, treatments and the cir-
cumstantial evidence surrounding the death; (ii) ideally, a
neuropathologist should be involved in the interpretation
of the brain pathology; (iii) a case should be made for
whole brain fixation and examination; and (iv) specific
protocols were recommended for tissue sampling and toxi-
cology, including sampling of key or ‘essential’ brain
regions known to be more vulnerable in epilepsy-related
injury, of potential relevance to the mode of death, and to
exclude other pathology. This document was formulated
to provide guidance for overall good practice for general
pathologists and neuropathologists, and to provide infor-
mation for coroners and other personnel dealing with
unexpected deaths in people with epilepsy.
The aim of this study was to review SUDEP PMs carried
out in different neuropathology centres across England,
including the methods practised and findings, to audit
against current standards from the Royal College of
Pathologists and to evaluate the contribution of brain
examination to these PM investigations.
Methods
PM reports from unexpected deaths in people with epi-
lepsy were audited from four participating neuropathol-
ogy centres serving different regions of England (South-
East, National Hospital for Neurology and Neurosurgery;
South-West, Plymouth, Derriford Hospital; North-East,
Newcastle-upon-Tyne, Royal Victoria Infirmary; and
North-West, Preston, LancashireTeachingHospitals). The
PM reports were ascertained from the period 1991–2014,
with 65.5% of these deaths occurring after the 2002 UK
National Sentinel audit into epilepsy-related deaths. In all
cases, there was either consent from the next of kin for use
of brain tissue and data in research or agreement from the
Coroner (Table 1). Cases were included in which a diagno-
sis of SUDEP or likely SUDEP was included in the conclu-
sion of the report, and other modes of epilepsy-related
deaths (e.g. status epilepticus) or those confirmed as acci-
dental deaths (e.g. head injury or drowning) were
excluded.
All aspects of clinical information regarding the
deceased’s epilepsy history and investigations, the circum-
stances surrounding the death, the findings at PM exami-
nation, including general histology and toxicology as well
as the pathological methods and findings from brain
examination, were extracted from the reports. Where
there was missing information for any component, for
example regarding EEG findings, this was recorded as
‘missing’, and no additional attempt was made to retrieve
data from clinical records, families or Coroner’s Offices.
Regarding the neuropathology, the findings were taken
from those detailed in the reports. Re-review of brain
material or slides was not undertaken. Statistical
analysis of the data was carried out with spss (v20 IBM,
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San Jose, Incorporation, CA, USA) using non-parametric
tests (including Mann–Whitney).
Results
We included PM reports of 145 individuals (89 males)
with a mean age of death of 40 years (range 2–82 years);
90% were Coroner’s autopsies. Neuropathological exami-
nations were based on the whole fixed brain in 111 cases
(76.6%), with some variation of practice noted between
centres (Table 1).
Clinical epilepsy history
The age of epilepsy onset was documented in 95/145
(66%) reports (mean age: 17.9 years, mean duration of
epilepsyof 23.2years;Table 2).Most (53%)hadaduration
of epilepsy of over 10 years; 12% had a recent onset/
diagnosis (occurring in the 2 years prior to death). There
were cases in this auditwhere deathoccurredwithinayear
of onset of epilepsy in people who only had a few seizures.
The underlying cause of epilepsy was ascertained from
73/145 (50%) of the reports. This was either stated as
such, or where highly epileptogenic pathologies such as
malformations of cortical development (MCD) or tumours
were identified, these were assumed to be the cause of
seizures. Underlying structural/metabolic causes [6] (pre-
viously termed ‘symptomatic’, focal or lesion-related epi-
lepsies) were the most frequent type, seen in 41% of the
whole series. Temporal lobe epilepsy or post-traumatic epi-
lepsy categories were based on clinical diagnosis alone and
not the identification of hippocampal sclerosis or old trau-
matic injuries (Table 2). Idiopathic and genetic epilepsies
each occurred in 5%; underlying genetic conditions were
Down syndrome (three cases), Dravet syndrome (two
cases) and Di George syndrome/velocardiofacial/22q11.2
deletion syndrome (two cases). In addition, there was one
case each of neurofibromatosis type 1 (pilocytic astrocy-
toma) and Tuberous Sclerosis in individuals with lesion-
related epilepsy. We found an association between
structural epilepsies and a shorter duration of epilepsy
prior to the sudden death (Figure 1).
Information regarding anti-epileptic drug treatments,
including the number of drugs as well as the type, was
documented in 121/145 of reports, with 54%maintained
on two or three medications. In 64/145 (44%) of reports,
the type(s) of seizures were not further detailed. General-
ized tonic–clonic seizures were themost common reported
seizure type, found in 76/145 (52%). Deaths often
occurred during the night, but nocturnal seizures were
only recorded in 8.3% of all cases (Table 2), and in only 10
caseswere previous episodes of status epilepticus reported.
General statements on seizure frequency/control, for
example ‘refractory epilepsy’ or ‘well-controlled epilepsy’,
were documented in 68% of reports; in 19%, a recent
deterioration in seizure control was specifically suggested
in the period prior to death.The time of the last seizurewas
documented in 28 reports, the majority occurring in the
24 h before death (Table 2). Information regarding rel-
evant clinical investigations, specifically EEG or MRI/
neuroimaging, was recorded in only around a third of all
reports.
Circumstances of death and recent seizures Overall, there
was more comprehensive documentation of the death
scene in thePMreports (Table 3). In126/145 (87%), there
was information regarding whether the death was wit-
nessedornot; thedeathswereunwitnessed in105cases. In
nineof the21witnessed cases, resuscitationattemptswere
Table 1. The regional distribution of 145 SUDEP cases from four centres in the UK contributing to this study
Region of
England* Centre
Period from which
PM reports taken
Cases after
2002 (%)
Number
of cases
Coronial
autopsies (%)
Neuropathology
examination based
on whole fixed brain (%)
South East London, National Hospital 1991–2013 52 79 81 92.4
South West Plymouth, Derriford Hospital 2007–2012 100 10 100 100
North West Preston, Lancashire Hospital 1999–2011 60 30 100 46.7
North East Newcastle Royal Victoria Infirmary 2009–2013 100 26 100 53.8
The sample from the centres represent a proportion of epilepsy deaths from these periods indicated. These were taken from archives where
consent for research purposes was available from the two centres in the South. In the two centres from the North of England, Coroner’s
permission was given for inclusion of data in cases included.*This denotes the approximate region of England served by this neuropathology
service.PM, post mortem.
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Table 2. Information available in PM reports regarding epilepsy histories and investigations
Clinical feature
Number (N = number where specific
information noted in report)
Percentage (of whole series
of 145 cases unless indicated)
Age of onset 17.9 years (range 0–82), N = 95 66
Duration of epilepsy 23.2 years (range 1–74), N = 96 66
Recent onset (1–2 years) 17 12
Intermediate duration (3–10 years) 13 9
Chronic epilepsy† (>10 years) 77 53
Epilepsy syndrome/cause specified 73 51
Idiopathic syndromes 5
Idiopathic (NOS) 3 2
Primary generalized epilepsy 2 1.4
Juvenile myoclonic epilepsy 2 1.4
Genetic syndromes 5
Dravet syndrome 2 1.4
DiGeorge syndrome 2 1.4
Down syndrome 3 2
Structural/metabolic 41
Post-traumatic epilepsy 9 6.3
Post-encephalitic 2 1.4
MCD 6 4
Tumours/operated lesions 10 7
TLE* 9 6.3
Based on clinical/EEG‡ 12 8.3
Perinatal infarcts (ulegyria) 4 3
Old infarcts 1 0.7
Alcohol-related seizures 6 4
Epilepsy syndrome unknown/not specified 72 49
Seizure types
’Seizures’ NOS 64 44
Nocturnal seizures documented 12 8.3
Generalized seizures 76 52
Focal/partial seizures§ 41 28
Myoclonic seizures 10 7
Episodes of Status epilepticus 10 6.9
Other seizure types¶ 16 11
General information of seizure frequency/control 99 68
Recent deterioration in control 28 19
No change in seizure pattern 32 22
Time of last seizure recorded prior to death 19.1 h (range 0–240) N = 28 (N = 25 in last 24 h)
History of previous CNS trauma 34 (N = 100) 34**
MRI/neuroimaging report available at time of PM 51 35
EEG report findings available at time of PM 46 32
Information on AED taken 121 83
No AED 6 5**
1 AED 36 30**
2–3 AEDs 65 54**
More than 3 AEDs 14 12**
The percentage of cases in the main epilepsy categories are shown in bold. *TLE cases were classified as such based on the clinical diagnosis only and not
by the identification of hippocampal sclerosis at PM. Similarly, cases were only classified as post-traumatic epilepsy when this was documented in the
reports and not based on the finding of old brain injury at PM. In cases with pathological identification of known epileptogenic tumours and malforma-
tions, such as dysembryoplastic neuroepithelial tumours and focal cortical dysplasia IIB, these were assumed as the underlying cause of
epilepsy.†Duration of epilepsy: In some cases, the report stated ‘onset of seizures in childhood’ without specifying exact age of onset; where the death was
in adulthood, a duration of >10 years was assumed.‡Cases of focal epilepsy based on clinical/EEG diagnosis included cases with frontal lobe epilepsy; in
some of these cases, no underlying pathology was confirmed at PM.§Focal/partial seizures included documented complex partial seizures in TLE.¶Other
seizure types noted in the PM reports included febrile seizures, atonic seizures and absence seizures. AEDs: This refers to information available of AEDs
prescribed at the time of death, and in all these cases, the named drugs were recorded in the PM reports.**In these cases, the percentage is in relation to
the number of cases where information was available rather than the entire series of 145 cases.MCD, malformation of cortical development; NOS, not
otherwise specified; AED, anti-epileptic drugs; TLE, temporal lobe epilepsy; PM, post mortem.
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followed by variable short survivals without regain of con-
sciousness; such cases are termed ‘nearmiss’ SUDEP in the
new classification system [7]. Convulsive seizureswere not
reported in all witnessed deaths, but terms such as
‘collapse/cardio-respiratory arrest/apnoea’ were used.
Information regarding the location of the body was
recorded in 114/145 (79%) of cases, mostly occurring in
the domestic environment. In 60% of all cases, the death
occurred in the bedroom setting (Table 3). In nine cases,
the body was found on the floor just adjacent to the bed.
Circumstantial evidence or witness statements from the
PM report suggested that the death had probably occurred
nocturnally or during sleep in 49%. In seven cases, the
body was found in a bath, but evidence of drowning was
not confirmed at PM. Detail was recorded regarding the
position of the body in 61/145 (42%) reports, with poten-
tial external airway compromise or prone position (typi-
cally face down on bed) noted in 39% (Table 3).
Neuropathology findings There was positive documenta-
tion of findings on external examination of the body of
potential relevance to a recent seizure in only 46/145
(32%) of cases, with tongue or lip biting reported in 21
cases (Table 4). Regarding the internal examination, evi-
dence of lung congestion or variable degrees of pulmo-
nary oedema was a frequent macroscopic finding,
reported in 99/145 (68%).
Macroscopic brain abnormalities were recorded in
76/145 (52%) (Table 4, Figure 2). These included poten-
tially epileptogenic lesions such as MCD, perinatal infarcts
and low-grade tumours. Specific macroscopic abnormali-
ties of the hippocampi were documented in 28% of cases,
including asymmetries, volume loss and mal-rotational
abnormalities. Mild degrees of brain swelling were
reported in 28% of cases; this was based on report descrip-
tions of swelling, excessive ‘fullness’ of the brain with flat-
tening of the gyri over the convexities (Figure 2A), an
exaggerated impression of the tentorium on the unci or by
assessment by the level of the Greenhall line. No signifi-
cant swelling or tonsillar herniation was reported in any
case. Brain weights were recorded in 136/145 (94%)
cases, and in 55, both the fresh and post-fixed fixed
weights were recorded. There was no significant difference
in brain weights, stratified according to age and sex,
between all SUDEP cases and reference control values [8]
(Figure S1). There was a significant increase in brain
weights in SUDEP cases with reported swelling compared
with those without swelling (P < 0.005). Mild increases in
brain weight were noted for females with macroscopically
normal or mildly swollen brains compared with age-
matched reference control values [8,9], but these were not
significant (Figure S1).
Microscopic neuropathology was reported in 89% of
cases overall. The most common potentially epileptogenic
pathologies either diagnosed or confirmedmicroscopically
included malformations (MCD and vascular) (15%),
tumours or mass lesions (7%) and hippocampal sclerosis
(21%; Table 4, Figure 2). Unilateral hippocampal sclerosis
was more common on the left side in this series.
Malrotational abnormalities of the hippocampus were
noted in14cases. Secondaryneuropathologies, probably a
consequence of seizures, included cerebellar atrophy of
varying degrees (41%); mild atrophy was noted histologi-
cally as evidenced by Purkinje cells loss in 12% and severe
atrophy, detectable macroscopically, in 29% (Table 4). Old
traumatic brain injuries were identified in 17%, which
included cases without a clinical diagnosis of post-
traumatic epilepsy. The commonest reported histological
finding was acute eosinophilic neuronal (AEN) change,
observed in 80/145 (55%) (Table 4, Figure 2C). In the
majority of cases, AEN was limited to the hippocampus,
typically the CA1/subiculum territory, but in 16%, more
widespread AEN was seen involving more than one brain
region, such as cortex, basal ganglia, thalamus and
cerebellum. In 6/7 ‘near-miss’ SUDEP cases, AEN was
Figure 1. Bar chart of epilepsy syndrome in relation to chronicity
of epilepsy in SUDEP cases. Recent onset epilepsy cases = onset in
the 2 years prior to death, intermediate duration = 3–10 years of
epilepsy prior to death, and chronic = more than 10 years of
epilepsy prior to death. There was a significant difference in the
epilepsy syndromes between the three groups with more
structural/lesion-related and temporal lobe epilepsies in recent and
intermediate cases compared with chronic epilepsy (P = 0.05).
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extensive. Clinical-pathological correlations showed sig-
nificantly more AEN in SUDEP cases where there was a
prone body position, external airways obstruction or
brain swelling, than without these features (P < 0.01)
(Figure 3). AEN was present in 68% of cases where a
seizure was reported in the 24 h prior to death. Further
minor histological changes noted included single foci of
axonal injury (one case), foci of inflammatory cell infil-
trates (11 cases), mineralization of basal ganglia and
vessels (six cases), gliosis of the amygdala (two cases), and
granule cell dispersion in the hippocampus in the absence
of hippocampal sclerosis (six cases).
We evaluated the identification of neuropathology in
relation to the method of brain examination. In 111/145
(76.6%), the neuropathological examination had been
carried out on the whole fixed brain. In 17% (24/145),
neuropathology examination was based on slicing of the
fresh brain at time of the autopsy by a neuropathologist
with sampling of selected regions for histology. In the
remaining 10/145 cases, the whole brain was not exam-
ined by a neuropathologist before histological analysis.
The number of tissue samples or blocks taken for histology
was recorded in 123 cases with a mean number of 12.5
blocks per case. The reports were also reviewed to investi-
gate whether six essential brain regions (amygdala,
hippocampus, watershed cortical region, cerebellum,
basal ganglia and brainstem) had been examined histo-
logically or if sampling was more limited. In 143 of the
reports, these data were retrievable, and in 58%, all
regions were examined, with one essential region absent
in 30% and more than one region not examined in 12%.
The most common region not submitted for histology was
the amygdala. Examination of the whole fixed brain com-
pared with other methods (P < 0.01) and examination
of all essential regions microscopically compared with
more limited sampling (P < 0.05) were associated with
Table 3. Circumstances of death
Category
Number (N = number
where specific information
noted in report)
Percentage (of whole
series of 145)
Death witnessed
Not witnessed 105 72
Witnessed 21 15
No information 19 13
Evidence of seizure around time of death
Seizure confirmed 18 12
Suspicious† 36 25
No evidence 49 34
No information 42 29
Nocturnal death*
Yes 71 49
No 41 28
No information 33 23
Location of body
In bed 62 43
Bedroom/floor next to bed 25 17
Bathroom 5 3.5
In bath 7 5
Other room/place 15 10
No detail of location 31 21.5
Position of body
Face down 43 30
Potential airways compromise‡ 13 9.0
No airways compromise 5 3.4
No detail on body position 84 58
†Suspicious signs for seizure includemicturition, tongue biting noted at scene or based on body position and disrupted environment. *Nocturnal
deaths included deaths during sleep/rest or where the person was found in bed even if the body was found during the day. The position of the
body in the majority of reports was specifically stated in the Coroner’s report and only in a minority of cases by the distribution of post mortem
hypostasis on the body.‡Potential external airways compromisewas defined as being presentwhen an object was found over themouth/face (e.g.
duvet, pillow) or the position of the neck suggested possible compromise to upper airways.
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Table 4. Neuropathological and PM findings
Pathology finding Number Percentage
External findings/general PM examination
Relevant to SUDEP* (cases with recent tongue /lip biting) 46 (21) 32 (14.5)
No relevant findings 62 43
Missing data 37 25
Pulmonary oedema/congestion 99 68
Macroscopic brain examination
Macroscopic abnormality (specific hippocampal abnormality†) 76 (41) 52 (28)
Mild brain swelling 41 28
Cases with microscopically confirmed localized lesion(s)‡ 66 46
Categories of potential ‘epileptogenic’ lesions
Malformation types (MCD and VM) 22§ 15
FCD type IIB 4
Tuberous sclerosis 1
Hemimegalencephaly 1
Grey matter heterotopia 3
Polymicrogyria 2
Ulegyria/perinatal cortical infarct (+ associated FCDIIId) 4
Other FCD types (FCD I and mild MCD) 3
Aicardi syndrome 1
Vascular malformations 7
Tumours/lesions 10 6.8
DNT, oligodendroglioma, PA, meningioma, astrocytoma II, ganglioglioma 6
Old surgical scars 4
Hippocampal sclerosis (confirmed on histology) 31$ 21
Left side 15
Right side 6
Bilateral 9
HIPMAL (macroscopic/microscopic) 14 9.7
Categories of secondary neuropathology (sequel of seizures)
Old traumatic brain injuries/contusions# 24 17
Old CVA 10 6.9
Mild cerebellar atrophy (microscopic) 17 12
Severe cerebellar atrophy (macroscopic) 42 29
Evidence of acute neuronal injury (AEN) 80¶ 55
CA1/subiculum 36
Other location (cortex, basal ganglia) 16
Extensive changes 25
*Relevant external PM findings include recent injuries or skin abrasions, evidence of incontinence prior to death, petechial haemorrhages, and
tongue or lip biting.†Specific hippocampal macroscopic abnormalities include evidence of volume reduction, asymmetry or rotational
abnormality.‡Localized pathological lesions included structural abnormalities that could be a cause or effect of seizures but excluded diffuse
microscopic changes as AEN, cerebellar atrophy as well as lesions of uncertain significance (e.g. HIPMAL). # Old traumatic brain injuries were
mainly cortical contusions.§A proportion had more than one MCD, for example complex malformations as polymicrogyria and heterotopia or
vascular malformations and cortical malformations were reported in four cases. Hippocampal sclerosis included all patterns of sclerosis but not
the finding of end folium gliosis or dentate granule cell dispersion alone ($In one case the side of sclerosis was not stated). HIPMAL was evident
macroscopically or only microscopically and either bilateral or unilateral.¶In three cases, the distribution of acute eosinophilic neurones (AEN)
was not further detailed.FCD, focal cortical dysplasia; MCD, malformations of cortical development; VM, vascular malformations (AVM and
telangiectasia); DNT, dysembryoplastic neuroepithelial tumour; PA, Pilocytic astrocytoma; CVA, cerebro-vascular accident; HIPMAL,
hippocampal malrotational abnormality.
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significantly higher rates of detecting relevant pathology
(Figure 4).
Categories of SUDEP Based on the data available from
each PM report, the cases were re-classified as definite,
probable, possible or ‘near-miss’ SUDEP according to the
latest classification [7] (Table 5). Definite and probable
SUDEP represented approximately three-quarters of
cases. The categories were compared between SUDEP PMs
carried out before and after 2002 (the time of publication
of the UK Sentinel audit); there were more definite SUDEP
cases reported after 2002 (46% vs. 20%), and overall clas-
sifications were significantly different between these eras
(P < 0.005).
Discussion
The main findings in this audit of SUDEP PMs were the
frequent findingof macroscopic brain abnormalities of rel-
evance to the cause or effects of epilepsy in over half the
Figure 2. Examples of some of the neuropathological abnormalities in SUDEP. (A) Evidence of brain swelling in SUDEP with gyral
flattening over convexities in a 39-year-old female. (B) Bilateral occipital ulegyric malformation following a focal perinatal ischaemic event,
simulating polymicrogyria, in a 52-year-old male with SUDEP. (C) Acute eosinophilic neuronal change in the CA1 sector with scattered
pyramidal neurones showing this alteration in SUDEP (arrow) (D). An individual with a clinical diagnosis of DiGeorge syndrome showing an
impression of exaggerated micro-columnar cytoarchitecture (arrows showing columns of >10 neurones and loss of horizontal lamination)
in the middle temporal lobe gyrus; also in this case, bilateral hippocampal atrophy was due to hippocampal sclerosis (E) with an impression
of incomplete hippocampal inversion with an upward pointing hilus. Bar is equivalent to 40 microns approximately in (C) and 250 microns
in (D).
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cases and microscopic abnormalities in 89%. Incomplete
documentation of clinical epilepsy historywas noted,with
more complete recording of the immediate circumstances
surrounding the death. Furthermore, brain abnormalities
weremore frequently detected following the recommended
practice of whole brainfixationandadherence toa system-
atic regional brain sampling protocol. This audit also dem-
onstrates that PM examinations have become more
thorough following theNational SentinelAudit,withmore
cases being categorized as ‘definite’ SUDEP.
In SUDEP, by definition, no cause of death is identified.
This has perhaps led to a misconception that brain exami-
nation is non-contributory and a rigorous, systematic
neuropathological examination not always necessary.
Previous national enquiries and audits have highlighted
that neuropathological examinations in epilepsy deaths
are often omitted (https://www.sudep.org/national
-audit-epilepsy-deaths-0 and http://www.ncepod.org.uk/
2006Report/index.html). In three previously reported
series of SUDEP which detailed brain PM findings,
neuropathology-negative cases represented between 34%
and 91% of cases [10–12] comparedwith only 11% in the
present series (Table 6). The range of pathologies reported
in all serieswere similar, but the frequency of all pathology
types, with the exception of old traumatic brain injuries,
was higher in the current series (Table 6). The age and sex
demographics are similar across the four series, and we
attribute the higher detection rates of pathology in our
series to the fact that examinations were based mainly on
fixed whole brains, subjected to systematic histological
sampling and conducted primarily by neuropathologists.
Indeed, it was previously noted that higher detection rates
for intracerebral pathology followed whole brain fixation
[10]. Within our four-centre cohort, there was some
regional variation in the method of brain examination,
which mainly reflected restrictions imposed by local
Figure 3. Acute eosinophilic neuronal (AEN) change in SUDEP
cases and clinical-pathological correlations. The presence or
absence of AEN change was correlated with four features identified
at post mortem: whether the death was presumed nocturnal/
during sleep; whether the body was found prone or there was a
suspicion from the position of the body of an element of external
airways compromise; the presence of pulmonary oedema/
congestion; whether or not there was brain swelling. Significant
differences are shown as **P = 0.001 and *P = 0.008.
Figure 4. Identification of relevant neuropathology in relation to
brain examination methods and sampling protocols. The number of
different neuropathologies identified either macroscopically and/or
microscopically per case was evaluated. These included the
following nine categories: old traumatic brain injury, tumours,
malformations, old infarcts, hippocampal sclerosis, hippocampal
malrotation, cerebellar atrophy and acute neuronal injury. This
was evaluated in all SUDEP cases, and only 11% had normal
neuropathology with the maximal number of neuropathologies
identified in a single case as six. This was further evaluated
according to the different protocols of (i) whole brain fixation, (ii)
no fixation of the brain/fresh sampling, and (iii) histological
samples only were evaluated by neuropathologist/general
pathologist (i.e. whole brain not available for neuropathologist to
review). There was a significant difference in the identification of
neuropathology between these methods (P < 0.01). In addition,
cases where all the essential brain regions were included (as
outlined in the Royal College of Pathologist’s document, Scenario 6
deaths in epilepsy, 2006), and cases where essential regions were
not included were compared; there was also a significant difference
in the number of pathologies identified between these different
methods (P < 0.05).
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coronial practice in individual cases. In 2006, the Royal
College of Pathologists issued guidelines on autopsy
practice in epilepsy deaths, recommending that a
neuropathologist should be involved in the interpretation
of the brain pathology and that a case should be made
for whole brain retention as best practice. This current
study was not designed to assess what proportion of
sudden epilepsy deaths is currently being referred to
neuropathologists in the UK. It does show, however, that
when such ‘best practice’ guidelines are implemented,
underlying pathology relevant to the cause of epilepsy and
death is significantly more likely to be detected.
Table 5. Categories of SUDEP
Category SUDEP
Number
(%) Definition*
Mean age
(years)
Number (%) of
cases pre-2002
(N = 50)
Number (%) of
cases post-2002
(N = 95)
Definite SUDEP 54 (37) All criteria met for SUDEP 16.8 10 (20) 44 (46.3)
All results of PM examination available
Probable SUDEP 57 (39) Criteria met for SUDEP apart from:
Missing toxicology report or
Missing organ histology report
15 25 (50) 32 (33.7)
Possible SUDEP 14 (10) A competing potential cause of death identified at PM* 34.8 4 (8) 10 (10.5)
Near Miss SUDEP 7 (5) Resuscitation following a seizure event with no recovery
but variable short survival of hours to few days
41.0 4 (8) 3 (3.2)
Combined SUDEP 13 (9) Possible + probable (10) 11.3 7 (14) 6 (6.3)
Probable + near miss (2)
Possible + near miss (1)
In addition to the SUDEP categories [7], we included a ‘combined SUDEP’ groupwhere criteria for two of the followingweremet in the same case:
‘possible’, ‘probable’ or ‘near-miss’ SUDEP.The age of deathwas older, but not significantly, in the possible SUDEP comparedwith the definite and
probable SUDEP groups. The categories were compared between SUDEP PMs carried out before and after 2002 (the time of publication of the
UK Sentinel audit); there were more definite SUDEP cases in the post-2002 group and overall significant differences in the categorization of the
SUDEPs between these two eras (P = 0.003).*Competing causes of death in this series included evidence of coronary artery disease (10),
cardiac hypertrophy (2), suspected early bronchopneumonia but not confirmed by histology (2), evidence of aspiration at PM not confirmed by
histology (3) and cases where the deceased was found in the bath but drowning not confirmed at post mortem (7): All these cases, on balance
of the available information, favoured SUDEP as the cause of death.
Table 6. Comparison of neuropathological findings in previous reported SUDEP series compared with present series [9–11]
Series Shields et al. [11] Black and Graham [10] Zhuo et al. [12] Current study
Number of cases 70 131 74 145
Nature of cohort Forensic autopsy series:
State of Kentucky, USA
Forensic autopsy series;
Glasgow, UK
Forensic autopsy series;
State of Maryland, USA
Neuropathology
centres, UK
Age range (years) 16–71 3–74 14–63 2–82
Male (%) 54% 64% 58.1% 61.1%
Cases with whole brain fixed No information 31.3% No information 76.6%
Cases with brain histology 73% 31.3% 32% 100%
Brain swelling No information – Not mentioned 28.3%
Traumatic lesions 27.1% % Not stated 13.5% 16.6%
Cortical malformations 0% – 6.8% 14.5%
Vascular malformations 2.8% – 4.1%
Hippocampal sclerosis 12.8% (cortical and
hippocampal atrophy)
7.3% 2.7% (‘gliosis’) 21.4%
Old infarcts – – 2.7% 6.9%
CNS tumours 3% – 2.8% 13%
Cerebellar atrophy 14.2% – 5.4% 40.7%
Acute hypoxic–ischaemic change/AEN No information % Not stated 1.4% (hippocampus) 55.2%
No pathology findings 54.2% 34% (Fixed brains) 41.9% 11%
91% (Fresh brains)
AEN, acute eosinophilic neurones.
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In parallel with the frequent detection of focal, poten-
tially epileptogenic, neuropathology, symptomatic/
structural epilepsies were the most common epilepsy
syndrome, estimated at 41% in this current series and
more frequent in SUDEP cases with shorter epilepsy histo-
ries than those with longer histories. In epidemiological
studies, the percentage of epilepsies considered to be
structural/localization-related varies from 9% to 62%,
largely dependent on age and the population studied [13].
In the UK, around a third of epilepsies are considered
idiopathic/genetic [14]. High rates of symptomatic/
structural epilepsy in SUDEP have been previously noted
[12,15,16], implying that a structural brain anomalymay
be a risk factor. The mechanism for any increased risk is
unknown, and no specific lesions have been singled out.
Hippocampal sclerosis was observed, unilaterally or bilat-
erally, in 21% in this series, which is less than reported in
surgical (33.6–66% [17,18]) and PM epilepsy series
(30.5–45% [19,20]). We did note more frequent involve-
ment of the left than the right hippocampus, which in
view of different anatomical connectivity with other brain
regions [21,22] may be of potential significance to the
mechanism of death. Hippocampal malrotational abnor-
malities were noted in 9.7% of SUDEP cases; the degree of
abnormality varied, with some apparent macroscopically
and others only visible microscopically, with hyper-
convolutional folds of CA1/subiculum in the hippocampal
body [23]. MRI studies have shown hippocampal
malrotation in people with epilepsy [24], but a frequency
of 19% has been reported in series of healthy volunteers
[3]. The significance of hippocampal malrotation in epi-
lepsy, or as a pathological risk factor for SUDEP, is therefore
uncertain. One limitation of this study is potential ascer-
tainment bias as it reflects current referral practice to only
four neuropathology centres; certain types of epilepsy
may be under-represented.
Detailed clinical information at the time of PM pro-
vides security regarding the epilepsy diagnosis as well as
directing tissue sampling to identify any underlying
subtle cortical abnormalities; this was not always avail-
able to pathologists based on recorded information in the
report. Circumstantial details of the death scene were
more consistently reported. The observation of SUDEP
primarily occurring in the domestic setting, many being
nocturnal and the majority in the bedroom and unwit-
nessed, is consistent with previous reports [25]. Informa-
tion regarding body position can provide further
information on potential contributing factors to the
mode of death, such as upper airways obstruction follow-
ing a seizure. Prone position of the body has been
strongly associated with risk for SUDEP, and has already
been established in SIDS [24]. Information on body posi-
tion was not always detailed, and there is potentially a
bias for including ‘positive’ findings in PM reports, such
as ‘body found face down’ and ‘tongue biting present’,
whereas negative/absent findings, which are equally
important, are not always stated. Only 30% of the series
were reported to be found in the prone position, but this
represents 70% of cases in which positional information
was reported. There were also several cases in this series
where the body was found on the floor adjacent to the
bed, suggesting a traumatic component to a final unwit-
nessed seizure. There are likely to be several causes of
SUDEP, not only in terms of the underlying epilepsy sub-
strate but also in the combination of pathophysiological
conditions that determine the final sequence of events, as
has been shown in SIDS [26]. Therefore, precise docu-
mentation of potential contributing agonal factors is
important in classifying each case for future research
purposes.
AEN was the most frequently reported microscopic
finding, more often observed in the hippocampus. This
cytopathological change is considered to represent acute
ante mortem neuronal injury, as supported by studies
showing HSP-70 and HIF-1α hippocampal neuronal
expression in SUDEP [27,28]. AEN is commonly stated as
being histologically detectable after 4–6 h following the
injurious cerebral ‘event’ [29], which could include either
cerebral hypoxia or a seizure, implicating a prolonged
agonal period in the majority of SUDEP cases. In the
MORTEMUS study, witnessed seizure-related deaths in an
epilepsy monitoring unit occurred within 3–8 min of the
terminal seizure [30]. In this current series, AEN was
noted in witnessed sudden deaths with short survival
times (‘near miss’ cases) but was also frequent in cases
with a seizure reported in the 24 h prior to death. In terms
of its cause, we showed a correlation of AEN with prone
body position as well as evidence of brain swelling, and
both these features could suggest impaired brain
perfusion/oxygenation. Aside from these issues regarding
timing and cause of AEN in SUDEP, its distribution could
reflect cellular/network dysfunction of relevance to
understanding the physiological mechanisms leading to,
or resulting from, the fatal seizure.
The reporting of brain swelling itself may also be rel-
evant to the final mechanism of death. Brain swelling
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has been quoted as a ‘common’ finding in SUDEP; cases
with tonsillar herniation have been described [31]. In
our series, brain swelling was noted in 28% to a mild or
‘non-significant’ degree with flattening of the gyri,
and/or prominent uncal grooving, but no cases with sig-
nificant swelling and tonsillar herniation were reported.
Objective measures of swelling, such as the Greenhall
line measurement, were rarely recorded, possibly due to
the lack of any caudal mesencephalic shift. Brain
weights, however, were consistently recorded, and
although dependent on gender, age, BMI, accuracy and
calibration of equipment, completeness and fixation state
of the specimen, we noted significantly higher brain
weights in SUDEP cases with swelling than without. We
did not, however, find any overall significant difference
between all SUDEP cases and age–gender-matched
control values. As seizure-related brain atrophy, as well
as lesions such as hemimegalencephaly, may alter brain
weight in either direction, we also analysed only SUDEP
cases without macroscopic brain pathology, but there
was only a trend for higher brain weights in females with
SUDEP than in controls. One possible cause of the brain
swelling is seizure-mediated vasogenic oedema as some-
times noted on post-ictal MRI and following status
epilepticus [32,33]. As even mild degrees of brain swell-
ing could potentially affect brainstem function through
compression, improved recording of brain swelling in
SUDEP PMs would be valuable.
Underlying genetic causes of epilepsies are increasingly
recognized [34] with some syndromes, such as Dravet
syndrome, associated with an increased risk of SUDEP
[35]. There is considerable interest in the identification of
candidate genes linked to SUDEP as those involving ion
channels [36,37]. It is unlikely that all SUDEP cases have
an underlying genetic cause, but identification of genetic
associations and mechanisms [38] affords an important
opportunity for understanding critical processes that
could be more widely implicated. It is possible that some
genetic epilepsies, for example mild forms of Dravet Syn-
drome, were under-recognized, but in this series, only a
minority had known underlying genetic disease. These
included two individuals with DiGeorge syndrome
(velocardiofacial syndrome/22q11.2 deletion syndrome),
which has high phenotypic variability affecting multiple
organs including the heart [39]. Although epilepsy is not
a prominent feature [40], brain malformations including
heterotopia [41], subtle FCD-like microcolumnar cortical
architecture [42] as well as hippocampal malrotational
abnormalities [43] have been previously reported in Di
George syndrome, as noted in one of our cases (Figure 2).
Attention to subtle malformations in this condition may
provide insight into causes of epilepsy and SUDEP. Fur-
thermore, microscopic malformations of the brainstem
and the dentate gyrus have been reported as relevant in
SIDS [44], and in this study, granule cell dispersion was
recorded in six SUDEP cases in the absence of sclerosis.
These observations suggest that a systematic analysis for
microscopic malformations in SUDEP is also warranted.
We were able to re-categorize the SUDEP cases accord-
ing to revised definitions [7], with more than three-
quarters of cases classified as definite or probable. In the
majority of probable cases, one or more pieces of informa-
tion were lacking from the records: Either the organ his-
tology or the laboratory toxicology report was not
available at the time of the neuropathology report or a test
was missing. We were able to demonstrate improved prac-
tice since the 2002 audit, with more cases assigned to the
definite category. Definite SUDEP cases also need to be
separately recorded from ‘possible SUDEP’ where compet-
ing pathologies or circumstances (including deaths in the
bath with no pathology evidence of drowning) imply an
element of uncertainty regarding the final mode of death.
This study identifies high rates of neuropathology in
SUDEP and justifies the current PMguidelines of the Royal
College of Pathologists for a thorough neuropathological
examination as recommended best practice. It highlights
improvements in PM practice since 2002 but also points
out areas that could be further improved to enable the
most accurate ascertainment of SUDEP in line with our
current knowledge of this condition. This will provide
more robust epidemiological data for national and epi-
lepsy deaths registers (e.g. sudep.org.uk) and for research
centres undertaking tissue-based SUDEP research (http://
csr.case.edu/index.php/Main_Page).
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Supporting information
Additional Supporting Information may be found in the
online version of this article at the publisher’s web-site:
Figure S1. Bar graph of mean brain weights in males (A)
and females (B)with SUDEP.These are shown for all SUDEP
cases for each gender, for cases with nomacroscopic brain
abnormality and cases with evidence of mild brain swell-
ing. Although increases in brain weight were noted,
particularly for females from 35 to 54 years with macro-
scopically normal brains or mildly swollen brains, these
were not significantly different from control values. There
was a significant difference between SUDEP caseswith and
without evidence of brain swelling (P < 0.005; not shown
on graph).The control values for brain weights were taken
fromDekaban [9]. For the SUDEP brainweight, fresh brain
weights were used; where the fixed brain weight only was
available, this was used and 22 g was subtracted from this
measurement (22 g was the mean difference in weight
increase following fixation from the 55 cases in this series
where both fresh to fixed weights were recorded; standard
deviation 56.99, range −122–166 g).
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